In this study, a network pharmacological analysis identified common targets for Tan-IIA and Cholangiocarcinoma disease, and KEGG and GO analyses revealed that these common targets were enriched in pathways associated with PI3K-Akt. This evidence concerns the gene AKT1 and cholangiocarcinoma.